 1. Recurrent low grade or intermediate grade B cell lymphoma or leukemia ALL or CLL, or newly diagnosed patients unable to receive or complete standard therapy OR diagnosis of intermediate B cell lymphoma with a treatment plan that will include high dose therapy and autologous stem cell transplantation. If a patient is less than 18, the lymphomaleukemia is highly aggressive i.e. lymphoblastic, Burkitt, ALL. 